Free Trial
ASX:SMR

Stanmore Resources (SMR) Stock Price, News & Analysis

Stanmore Resources logo

About Stanmore Resources Stock (ASX:SMR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.20 million shs
Average Volume
N/A
Market Capitalization
A$1.48 billion
P/E Ratio
5.40
Dividend Yield
7.45%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stanmore Resources and its competitors with MarketBeat's FREE daily newsletter.

SMR Stock News Headlines

Ord Minnett Keeps Their Buy Rating on Stanmore Resources Ltd (SMR)
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Citi Sticks to Their Buy Rating for Stanmore Resources Ltd (SMR)
See More Headlines

SMR Stock Analysis - Frequently Asked Questions

Stanmore Resources Limited (ASX:SMR) announced its quarterly earnings results on Tuesday, February, 12th. The company reported $0.08 EPS for the quarter. Stanmore Resources had a net margin of 10.57% and a trailing twelve-month return on equity of 15.63%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stanmore Resources investors own include Aldeyra Therapeutics (ALDX), Biodexa Pharmaceuticals (BDRX), Candel Therapeutics (CADL), Cleanspark (CLSK), CXApp (CXAI), DiaMedica Therapeutics (DMAC) and Dyne Therapeutics (DYN).

Company Calendar

Last Earnings
2/12/2019
Today
7/17/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Coking Coal
Sub-Industry
Fabricated Products
Current Symbol
ASX:SMR
CIK
N/A
Fax
N/A
Employees
440
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.44
Trailing P/E Ratio
5.40
Forward P/E Ratio
N/A
P/E Growth
0.03
Net Income
A$268.40 million
Net Margins
10.57%
Pretax Margin
N/A
Return on Equity
15.63%
Return on Assets
7.75%

Debt

Debt-to-Equity Ratio
44.24
Current Ratio
1.01
Quick Ratio
1.27

Sales & Book Value

Annual Sales
A$2.54 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.69
Book Value
A$1.95 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
901,390,000
Free Float
N/A
Market Cap
A$1.48 billion
Optionable
Not Optionable
Beta
0.21
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (ASX:SMR) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners